...
首页> 外文期刊>Jornal Brasileiro de Pneumologia >Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth?
【24h】

Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth?

机译:哮喘或慢性阻塞性肺病患者的客观吸烟指标与自我报告的吸烟状况之间的比较:我们的患者告诉我们事实吗?

获取原文

摘要

OBJECTIVE: Smoking prevalence is frequently estimated on the basis of self-reported smoking status. That can lead to an underestimation of smoking rates. The aim of this study was to evaluate the difference between self-reported smoking status and that determined through the use of objective measures of smoking at a pulmonary outpatient clinic. METHODS: This was a cross-sectional study involving 144 individuals: 51 asthma patients, 53 COPD patients, 20 current smokers, and 20 never-smokers. Smoking status was determined on the basis of self-reports obtained in interviews, as well as through tests of exhaled carbon monoxide (eCO) and urinary cotinine. RESULTS: All of the asthma patients and COPD patients declared they were not current smokers. In the COPD and asthma patients, the median urinary cotinine concentration was 167 ng/mL (range, 2-5,348 ng/mL) and 47 ng/mL (range, 5-2,735 ng/mL), respectively (p 0.0001), whereas the median eCO level was 8 ppm (range, 0-31 ppm) and 5 ppm (range, 2-45 ppm), respectively (p 0.05). In 40 (38%) of the patients with asthma or COPD (n = 104), there was disagreement between the self-reported smoking status and that determined on the basis of the urinary cotinine concentration, a concentration 200 ng/mL being considered indicative of current smoking. In 48 (46%) of those 104 patients, the self-reported non-smoking status was refuted by an eCO level 6 ppm, which is also considered indicative of current smoking. In 30 (29%) of the patients with asthma or COPD, the urinary cotinine concentration and the eCO level both belied the patient claims of not being current smokers. CONCLUSIONS: Our findings suggest that high proportions of smoking pulmonary patients with lung disease falsely declare themselves to be nonsmokers. The accurate classification of smoking status is pivotal to the treatment of lung diseases. Objective measures of smoking could be helpful in improving clinical management and counseling.
机译:目的:经常根据自我报告的吸烟状况估算吸烟率。这可能会导致低估吸烟率。这项研究的目的是评估自我报告的吸烟状况与通过在肺科门诊诊所使用客观吸烟指标确定的吸烟状况之间的差异。方法:这是一项横断面研究,涉及144位患者:51位哮喘患者,53位COPD患者,20位当前吸烟者和20位从不吸烟者。吸烟状况是根据访谈中获得的自我报告,以及呼出气中一氧化碳(eCO)和尿液可替宁的含量来确定的。结果:所有哮喘患者和COPD患者都宣布他们不是当前吸烟者。在COPD和哮喘患者中,尿中可替宁的中位浓度分别为167 ng / mL(范围2-5,348 ng / mL)和47 ng / mL(范围5-2,735 ng / mL)(p <0.0001),而eCO中位数分别为8 ppm(范围为0-31 ppm)和5 ppm(范围为2至45 ppm)(p <0.05)。在40名(38%)患有哮喘或COPD的患者中(n = 104),自我报告的吸烟状况与根据尿中可替宁浓度确定的吸烟状况存在分歧,认为该浓度> 200 ng / mL指示当前吸烟。在这104名患者中的48名(46%)中,自我报告的非吸烟状态被eCO水平> 6 ppm驳斥,这也被认为是当前吸烟的指示。在30名(29%)患有哮喘或COPD的患者中,尿中的可替宁浓度和eCO水平均掩盖了该患者声称自己不是当前吸烟者的信息。结论:我们的研究结果表明,吸烟的肺部疾病患者中有很大一部分错误地宣布自己是不吸烟者。吸烟状态的准确分类对于治疗肺部疾病至关重要。客观的吸烟措施可能有助于改善临床管理和咨询。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号